(1 - 9 von 11
)
GSK Announces CHMP Positive Opinion for Labelling Update to Relvar...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Global Head of Respiratory Franchise GSK, said: "There are many asthma patients in Europe who, despite being adequately controlled on a twice-daily ICS/LABA, are still ...
EU approves label update to Relvar Ellipta in patients with ...
www.pharmabiz.com
— Jonathan Sweeting, SVP and head of global respiratory franchise GSK, said: "Patients with asthma can continue to experience symptoms despite ... › News...
Innoviva, GSK: EU Approves Label Update To Relvar Ellipta ...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: 'Patients with asthma can continue to experience symptoms despite being adequately controlled and these symptoms can ...
GSK's Nucala improves control of severe asthma - PharmaTimeswww.pharmatimes.com › news › g...
www.pharmatimes.com
... patients who are not well controlled by omalizumab,” noted Jonathan Sweeting, SVP and head, Global Respiratory Franchise at GSK.
sortiert nach Relevanz / Datum